Analysis and Commentary STEVEN GROSSMAN 3/12/16 Analysis and Commentary STEVEN GROSSMAN 3/12/16 Four Key Points for Hill Day 2016 Read More Analysis and Commentary STEVEN GROSSMAN 3/4/16 Analysis and Commentary STEVEN GROSSMAN 3/4/16 Califf Debuts on Capitol Hill with Two Priorities Read More Analysis and Commentary STEVEN GROSSMAN 2/27/16 Analysis and Commentary STEVEN GROSSMAN 2/27/16 "Everything is a high priority" for the FDA today Read More Analysis and Commentary STEVEN GROSSMAN 2/19/16 Analysis and Commentary STEVEN GROSSMAN 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More Analysis and Commentary STEVEN GROSSMAN 2/12/16 Analysis and Commentary STEVEN GROSSMAN 2/12/16 Of Smoke, Mirrors, and Advocacy Participation Read More Analysis and Commentary STEVEN GROSSMAN 2/5/16 Analysis and Commentary STEVEN GROSSMAN 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More Analysis and Commentary STEVEN GROSSMAN 1/29/16 Analysis and Commentary STEVEN GROSSMAN 1/29/16 The Prompt Confirmation of a New Commissioner Read More Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More Analysis and Commentary STEVEN GROSSMAN 1/15/16 Analysis and Commentary STEVEN GROSSMAN 1/15/16 A Thank You ... and Now on to FY 17 Read More Analysis and Commentary STEVEN GROSSMAN 1/8/16 Analysis and Commentary STEVEN GROSSMAN 1/8/16 The Demonstration of Accountability to Multiple Stakeholders Read More Analysis and Commentary STEVEN GROSSMAN 12/18/15 Analysis and Commentary STEVEN GROSSMAN 12/18/15 And Now for FY 17 -- Starting January 12 Read More Analysis and Commentary STEVEN GROSSMAN 12/11/15 Analysis and Commentary STEVEN GROSSMAN 12/11/15 And Still We Hold Our Breath in Hope Read More Analysis and Commentary STEVEN GROSSMAN 12/4/15 Analysis and Commentary STEVEN GROSSMAN 12/4/15 When Can You "Show Me the Money"? Read More Analysis and Commentary STEVEN GROSSMAN 11/20/15 Analysis and Commentary STEVEN GROSSMAN 11/20/15 Of News, No News, and the Fine Art of Salmon Policy Riders Read More Analysis and Commentary STEVEN GROSSMAN 11/16/15 Analysis and Commentary STEVEN GROSSMAN 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More Analysis and Commentary STEVEN GROSSMAN 11/6/15 Analysis and Commentary STEVEN GROSSMAN 11/6/15 The Clock Is Ticking; Act Now Please! Read More Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More Analysis and Commentary STEVEN GROSSMAN 10/23/15 Analysis and Commentary STEVEN GROSSMAN 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More Analysis and Commentary STEVEN GROSSMAN 10/16/15 Analysis and Commentary STEVEN GROSSMAN 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More Analysis and Commentary STEVEN GROSSMAN 10/9/15 Analysis and Commentary STEVEN GROSSMAN 10/9/15 Turmoil at the Top of the Hill Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 3/12/16 Analysis and Commentary STEVEN GROSSMAN 3/12/16 Four Key Points for Hill Day 2016 Read More
Analysis and Commentary STEVEN GROSSMAN 3/4/16 Analysis and Commentary STEVEN GROSSMAN 3/4/16 Califf Debuts on Capitol Hill with Two Priorities Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/16 Analysis and Commentary STEVEN GROSSMAN 2/27/16 "Everything is a high priority" for the FDA today Read More
Analysis and Commentary STEVEN GROSSMAN 2/19/16 Analysis and Commentary STEVEN GROSSMAN 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More
Analysis and Commentary STEVEN GROSSMAN 2/12/16 Analysis and Commentary STEVEN GROSSMAN 2/12/16 Of Smoke, Mirrors, and Advocacy Participation Read More
Analysis and Commentary STEVEN GROSSMAN 2/5/16 Analysis and Commentary STEVEN GROSSMAN 2/5/16 Hunting for the Wheat in the Chaff of Hyperbole Read More
Analysis and Commentary STEVEN GROSSMAN 1/29/16 Analysis and Commentary STEVEN GROSSMAN 1/29/16 The Prompt Confirmation of a New Commissioner Read More
Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More
Analysis and Commentary STEVEN GROSSMAN 1/15/16 Analysis and Commentary STEVEN GROSSMAN 1/15/16 A Thank You ... and Now on to FY 17 Read More
Analysis and Commentary STEVEN GROSSMAN 1/8/16 Analysis and Commentary STEVEN GROSSMAN 1/8/16 The Demonstration of Accountability to Multiple Stakeholders Read More
Analysis and Commentary STEVEN GROSSMAN 12/18/15 Analysis and Commentary STEVEN GROSSMAN 12/18/15 And Now for FY 17 -- Starting January 12 Read More
Analysis and Commentary STEVEN GROSSMAN 12/11/15 Analysis and Commentary STEVEN GROSSMAN 12/11/15 And Still We Hold Our Breath in Hope Read More
Analysis and Commentary STEVEN GROSSMAN 12/4/15 Analysis and Commentary STEVEN GROSSMAN 12/4/15 When Can You "Show Me the Money"? Read More
Analysis and Commentary STEVEN GROSSMAN 11/20/15 Analysis and Commentary STEVEN GROSSMAN 11/20/15 Of News, No News, and the Fine Art of Salmon Policy Riders Read More
Analysis and Commentary STEVEN GROSSMAN 11/16/15 Analysis and Commentary STEVEN GROSSMAN 11/16/15 Please Write to Appropriators NOW ... The Clock's Still Ticking Read More
Analysis and Commentary STEVEN GROSSMAN 11/6/15 Analysis and Commentary STEVEN GROSSMAN 11/6/15 The Clock Is Ticking; Act Now Please! Read More
Analysis and Commentary STEVEN GROSSMAN 10/30/15 Analysis and Commentary STEVEN GROSSMAN 10/30/15 So ... How Do We Help FDA Get a Fair Cut of the Extra $40 Billion? Read More
Analysis and Commentary STEVEN GROSSMAN 10/23/15 Analysis and Commentary STEVEN GROSSMAN 10/23/15 The Ryan Era? One Step Closer to the End-Game! Read More
Analysis and Commentary STEVEN GROSSMAN 10/16/15 Analysis and Commentary STEVEN GROSSMAN 10/16/15 FDA Mission Still "at Risk" Says Science Board Read More
Analysis and Commentary STEVEN GROSSMAN 10/9/15 Analysis and Commentary STEVEN GROSSMAN 10/9/15 Turmoil at the Top of the Hill Read More
